Tao Zhang
Clinical trials sponsored by Tao Zhang, explained in plain language.
-
New drug cocktail aims to shrink Hard-to-Treat GI cancers
Disease control Not yet recruitingThis study tests a combination of two drugs (zanidatamab and tislelizumab) plus chemotherapy or radiation in people with HER2-positive gastrointestinal cancers, including rectal, stomach, and colorectal cancers. The goal is to see if this treatment can shrink tumors before surger…
Phase: PHASE2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated May 26, 2026 11:32 UTC
-
New triple therapy aims to control advanced colon cancer with liver spread
Disease control Not yet recruitingThis study tests a new combination of drugs and short radiation therapy for people with advanced colorectal cancer that has spread to the liver and cannot be removed by surgery. The goal is to see if this combination is safer and works better than standard third-line treatments. …
Phase: PHASE2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated May 20, 2026 11:56 UTC